References in periodicals archive ?
Biochemical data collected included: serum alanine transaminase (ALT); aspartate transaminase (AST); TSH; fT4; fT3; anti-thyroid peroxidase (anti-TPO) antibodies; anti-thyroglobulin (anti-Tg) antibodies and anti-TSH receptor antibodies (TRAb).
FT4 was 15.6 and the lower limit was 0.02 and the mean S.
They found a 40 per cent increase in existing Atrial fibrillation for patients in the highest quartile of fT4 levels compared to patients in the lowest, and a 16 per cent increase in newly developing Atrial fibrillation during 3-years of follow up.
"The next step for researchers is to conduct a randomized trial to see if targeting a lower versus a higher upper range of fT4 in patients receiving thyroid hormone replacement therapy leads to a lower risk of atrial fibrillation and stroke along with other possible heart-related issues, like atherosclerosis," Dr.
Instrument and reagent Serum levels of TSH, FT4, and FBG were measured by using Kermankult UniCel Dx1800 automatic chemical immunoassay analyzer; 25-OH-D level was measured by using Roche Elecsys 2010 electro-chemiluminescence auto immunoassay analyzer and kits.
Reference intervals were derived from the 5th and 95th percentile values of TSH, FT4 and TT3.
Peripheral blood samples were obtained after 12 hours of fasting, and low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C), total cholesterol (TC), triglycerides (TGC), fasting blood glucose (FBG), fasting insulin (FI), thyroid stimulating hormone (TSH), free T3 (FT3), free T4 (FT4), highly sensitive C-reactive protein (hsCRP), and hemoglobin A1c (HbA1c) levels were analyzed.
The serum TSH levels were below 0.005 [micro]IU/mL, and the fT4 and fT3 levels were above upper limit of normal (1.71 ng/dL, 4.4 pg/mL) in all the patients.
Shristi Rawal, Ph.D., from the National Institutes of Health in Bethesda, Md., and colleagues conducted a case-control study in which thyroid markers (fT3, fT4, and TSH) were measured and the fT3-to-fT4 ratio was derived across four visits in pregnancy.
The thyroid-stimulating hormone (TSH) and free thyroxine (FT4) were dosed using a third generation immunoenzymatic assay (Siemens, USA) in serum obtained from venous blood samples after an overnight fast and centrifugation.
Low TSH and FT4 are associated with secondary (central) hypothyroidism, non-thyroidal illness (undetectable concentrations not typical), or triiodothyronine (T3) thyrotoxicosis (1).
The parameters of gender; age; body weight; serum TSH, FT3, and FT4 levels; minimum and maximum temperature on the day of FDG-PET/CT imaging and maximum temperature one day before; and the deference of temperature were compared.
Acronyms browser ?
Full browser ?
- FTA Binational Secretariat
- FTA Binational Secretariats
- FTA Receiver
- FTA, FTA-ABS
- FTA-ABS test
- FTA-ABS test